[Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk]
[Article in
Italian]
Affiliations
- PMID: 2967519
Item in Clipboard
[Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk]
[Article in
Italian]
Quad Sclavo Diagn.
1987 Jun.
Abstract
We report the results of the vaccinations against hepatitis B carried out with vaccine H-B-VAX of the commercial firm (Merck Sharp and Dohme), on 102 U.S.L. 32 hospital workers in Portomaggiore (Ferrara, Italy). The vaccine rendered 92% of the subjects inoculated immune and the incidence of secondary effects was low.
Similar articles
-
[Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].Przegl Epidemiol. 1991;45(1-2):11-6. Przegl Epidemiol. 1991. PMID: 1839075 Polish.
-
[Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].Minerva Med. 1987 Aug 31;78(16):1233-41. Minerva Med. 1987. PMID: 2957614 Italian.
-
Low dose hepatitis B vaccination in children: benefit of low dose boosters.N Z Med J. 1988 Jun 8;101(847 Pt 1):370-1. N Z Med J. 1988. PMID: 2970604
-
[Preventive hepatitis B vaccination].Z Arztl Fortbild (Jena). 1990;84(8):381-3. Z Arztl Fortbild (Jena). 1990. PMID: 2143042 Review. German. No abstract available.
-
[Viral hepatitis and immunoprophylaxis].Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):134-45. Zentralbl Bakteriol Mikrobiol Hyg B. 1985. PMID: 2986380 Review. German.
Cited by
-
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection.Bone Marrow Transplant. 2023 Mar;58(3):265-272. doi: 10.1038/s41409-022-01880-7. Epub 2022 Dec 1. Bone Marrow Transplant. 2023. PMID: 36456810
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials